What does CUSIP 007002108 represent in this 13F holders report?

CUSIP 007002108 is the security identifier for ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 used to aggregate holder disclosures.

How many institutions held ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 in Q2 2022?

97 institutional investors reported ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 for Q2 2022. Use the holders table for investor-level position and value details.

Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)

CUSIP: 007002108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.0001
Shares outstanding: 9,599,852
Total 13F shares: 37,871,013
Share change: +4,806,196
Total reported value: $553,032,820
Put/Call ratio: 53%
Price per share: $14.60
Number of holders: 97
Value change: +$48,530,334
Number of buys: 63
Number of sells: 29

Quarterly Holders Quick Answers

What is CUSIP 007002108?
CUSIP 007002108 identifies ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 007002108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	78%	7,447,141	$148,719,000	—	31 Mar 2022	13F
Avidity Partners Management LP	13F	Company	33%	3,120,000	$62,306,000	—	31 Mar 2022	13F
RTW INVESTMENTS, LP	13F	Company	31%	2,989,482	$59,700,000	—	31 Mar 2022	13F
Abingworth LLP	13F	Company	22%	2,115,385	$42,160,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	17%	1,618,107	$32,314,000	—	31 Mar 2022	13F
Polar Capital Holdings Plc	13F	Company	16%	1,543,670	$30,827,000	—	31 Mar 2022	13F
COWEN AND COMPANY, LLC	13F	Company	16%	1,500,055	$29,956,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	11%	1,071,655	$21,401,000	—	31 Mar 2022	13F
Cormorant Asset Management, LP	13F	Company	7.8%	750,000	$14,978,000	—	31 Mar 2022	13F
JOHNSON & JOHNSON	13F	Company	7.6%	728,944	$14,557,000	—	31 Mar 2022	13F
DAFNA Capital Management LLC	13F	Company	7.5%	715,872	$14,296,000	—	31 Mar 2022	13F
Foresite Capital Management V, LLC	13F	Company	7.1%	680,000	$13,580,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	7.1%	677,810	$13,536,000	—	31 Mar 2022	13F
Decheng Capital Management III (Cayman), LLC	13F	Company	6%	580,000	$11,583,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	5.9%	568,566	$11,354,000	—	31 Mar 2022	13F
Tri Locum Partners LP	13F	Company	5.5%	523,256	$10,449,000	—	31 Mar 2022	13F
Ikarian Capital, LLC	13F	Company	5.3%	507,348	$10,132,000	—	31 Mar 2022	13F
Laurion Capital Management LP	13F	Company	4.6%	441,518	$8,817,000	—	31 Mar 2022	13F
Sofinnova Investments, Inc.	13F	Company	4.3%	416,289	$8,313,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	4.1%	398,109	$7,950,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	4.1%	396,768	$7,923,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	4.1%	392,798	$7,844,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	4.1%	391,835	$7,824,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	2.9%	275,896	$5,510,000	—	31 Mar 2022	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	2.9%	275,000	$5,492,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	2.4%	228,031	$4,554,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	2.3%	221,127	$4,416,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	2.1%	204,200	$4,078,000	—	31 Mar 2022	13F
Granite Point Capital Management, L.P.	13F	Company	2.1%	197,898	$3,952,000	—	31 Mar 2022	13F
Woodline Partners LP	13F	Company	2%	196,504	$3,924,000	—	31 Mar 2022	13F
BAILLIE GIFFORD & CO	13F	Company	1.9%	181,626	$3,627,000	—	31 Mar 2022	13F
Foresite Capital Opportunity Management V, LLC	13F	Company	1.8%	170,000	$3,395,000	—	31 Mar 2022	13F
Altium Capital Management LLC	13F	Company	1.6%	155,000	$3,095,000	—	31 Mar 2022	13F
Informed Momentum Co LLC	13F	Company	1.4%	131,770	$2,631,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	1.3%	122,099	$2,438,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	1.1%	103,423	$2,065,000	—	31 Mar 2022	13F
Global IMC LLC	13F	Company	0.96%	92,202	$1,841,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.96%	91,775	$1,833,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.82%	78,613	$1,570,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.7%	66,803	$1,335,000	—	31 Mar 2022	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.69%	66,626	$1,331,000	—	31 Mar 2022	13F
Tekla Capital Management LLC	13F	Company	0.66%	63,329	$1,265,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.85%	81,597	$1,233,000	—	31 Mar 2022	13F
Allianz Asset Management GmbH	13F	Company	0.62%	59,215	$1,183,000	—	31 Mar 2022	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.53%	50,715	$1,013,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.37%	35,538	$710,000	—	31 Mar 2022	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.36%	34,942	$698,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.33%	31,679	$633,000	—	31 Mar 2022	13F
Golden State Equity Partners	13F	Company	0.31%	30,014	$599,000	—	31 Mar 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.29%	28,000	$559,000	—	31 Mar 2022	13F

Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q2 2022

As of 30 Jun 2022, Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by 97 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,871,013 shares. The largest 10 holders included ORBIMED ADVISORS LLC, RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, Abingworth LLP, BlackRock Inc., Cormorant Asset Management, LP, MORGAN STANLEY, Polar Capital Holdings Plc, Candriam S.C.A., and VANGUARD GROUP INC. This page lists 97 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.